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ABSTRACT
A MATHEMATICAL GROWTH MODEL OF THE VIRAL POPULATION IN
EARLY HIV-1 INFECTIONS
SEPTEMBER 2011
ELENA EDI GIORGI, ”Laurea,” UNIVERSITA’ DI PISA
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF SOUTHERN CALIFORNIA LOS ANGELES
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Panayotis Kevrekidis
In this thesis we develop a mathematical model to describe HIV-1 evolution during
the first stages of infection (approximately within 40-60 days since onset), when one
can assume exponential growth and random accumulation of mutations under a neu-
tral drift. We analyze the Hamming distance (HD) distribution under different models
(synchronous and asynchronous) in the absence of selection and recombination. In the
second chapter of the thesis, we introduce recombination and develop a combinatorial
approach to estimate the new HD distribution. We conclude describing a T statistic to
test significance differences between the HD of two genetic samples, which we derive
using U-statistics.
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C H A P T E R 1
INTRODUCTION
1.1 The HIV pandemic
June 2011 marks the 30th anniversary of the first formal report of the disease today
known as AIDS. According to the international organization AVERT there were 33.3
million people worldwide living with HIV/AIDS in 2009, with 2.6 million new HIV
infections per year, and 1.8 million annual deaths due to AIDS (Figure 1). While in
the western world people have access to treatment facility and drugs, this is not true
in Africa, which remains the continent most plagued by the disease. Two thirds of all
infected people live in South Africa (Figure 2), where teenagers, according to the Henry
Kaiser Foundation, have a 50% chance of contracting HIV over the course of their lives.
Since the start of the infection, nearly 15 million African children have lost one or both
parents to AIDS, and there are villages where a whole generation has been wiped out
by the disease and children have grown unsupervised. While the mean life expectancy
in the western world keeps increasing, countries with high HIV prevalence have seen a
sharp decline because of the disease (Figure 3). The United Nations has called this the
”Greatest reversion in quality of life in human history.”
The CDC estimated that, in 2007, 1.2 million people were living with HIV/AIDS in
the US alone. here, after the introduction of highly effective antiretroviral therapy, the
1
Figure 1. Number of people living with HIV, number of new infections, and
number of AIDS deaths worldwide from 1990 until 2008. Figure
from Wikipedia.
2
Figure 2.4
Global prevalence of HIV, 2009
Source: UNAIDS.
Figure 2. Adult prevalence of HIV by country, at the end of 2009. Figure from
UNAIDS.
number of AIDS diagnoses saw a steady decline until 2001, and have been on the raise
since then [24].
As of today, we still don’t have an effective vaccine to fight HIV (where by effective,
we mean able to grant at least a 70% protection). The challenges are in the nature of
the virus, which attacks the building blocks of the host’s immune system. Furthermore,
a high mutation rate allows HIV to find successful escapes to immunological responses.
New viral particles are produced every two days, thus quickly escaping the host’s im-
mune response. Due to the high variability of the virus, a lifetime cocktail of 3-4 drugs
is required for therapy, as one alone is not sufficient.
3
Life expectancy 
UN Dept Economics and Social Affairs, 2001 
Figure 3. Effect of HIV/AIDS on life expectancy. Note that countries with
HIV/AIDS low prevalence have more or less continuous increases in
life expectancy since the 1950s. On the other hand, countries with
high prevalence have a profound decrease since the late 1980s. In
2005, life expectancy in Botswana was 36, 6 years lower than in the
1950s.
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1.2 Time course of the infection
The acute phase of the infection, which typically covers the first 2-4 weeks, is char-
acterized by a rapid growth in viral load (the concentration of virus in the blood), and
a sharp decline in T-lymphocites [49, 50], the cells of the immune system that are at-
tacked by the virus. For some patients, this is associated to flu-like symptoms (Figure 4).
Within 6-8 weeks, peak viremia (the maximum in viral load) is reached, after which the
concentration of virus starts declining until it stabilizes at a level that remains unchanged
for years. This is called the chronic phase, which is asymptomatic, but during which the
virus keeps mutating and genetic diversity within the viral population increases dramat-
ically [76, 60, 64, 78]. In the absence of therapy, infected individuals survive roughly a
decade, at the end of which viral loads abruptly increase again and patients typically die
of an opportunistic infection [51].
A correlation has been observed between peak viremia and the progression of the
disease [16, 69]. Despite the mild symptoms experienced by patients during the early
phase of the infection, the virus severely damages the host’s immune system. This is
also when patients are most contagious due to high viral loads and the fact that most
don’t even realize they have been infected. In terms of vaccine design, it is very impor-
tant to characterize the virus this early in the infection and understand its interactions
with the immune response, as a vaccine should in theory be able to protect the immune
system and keep the viral loads from spiking, thus improving disease progression and
lowering infectivity.
However, until a few years ago, HIV genetic data from acute patients was unavail-
able, mostly because most patients don’t realize they have contracted the virus until much
later into the infection. It is only recently that we were able to obtain data from patients
within the very first weeks of the infection, thus enabling us to characterize the virus
5
during the acute phase. In order to do so, we developed the new analytical tools that we
will describe over the course of this thesis.
Figure 4. A schematization of the timeline of a typical HIV infection. The viral
load is shown in red, and the T-lymphocite counts in blue. These cells
are important components of our immune system and over the course
of the infection the reservoir gets depleted by the virus until the pa-
tient dies of an ”opportunistic infection.” The maximum in viral load
occurs within the first 4-6 weeks since the infection and is correlated
to disease progression, hence it is important to understand the viral
dynamics within these very first phase of the infection.
1.3 A genetic bottleneck
It has been shown that the viral population in chronically infected patients is con-
stantly evolving under immune selection [76, 60], thus yielding a genetically diverse
quasispecies [64, 78]. However, acute samples from either sexual or mother-to-infant
transmissions are associated with a population bottleneck [79, 12, 48, 15, 13, 82]. Even
6
when the viral population in the donor is extremely diverse (e.g. chronic infection), the
population in the recipient, when sampled early, is found to be either completely ho-
mogeneous or derived from very few genetically distinct strains [12, 34]. In particular,
when we looked at data from heterosexually infected patients, we saw that on average
80% of the infections had been initiated by a single strain [34, 80].
This kind of evidence motivated the following research questions: how many virions
or infected cells enter the host to initiate the infection, and does the multiplicity of the
infection affect the course of the disease? How early does immune selection pressure
start driving viral evolution? Do the viruses that make it through the bottleneck have
common characteristics? These questions become relevant in light of a vaccine design
study: if, out of a diverse viral population, only a few are able to infect a new host, then
these are the viruses that an effective vaccine should target.
1.4 Outline of this dissertation
While the viral kinetics in the early phases of HIV infection have been studied
through ODE mathematical models [30, 52], no model was available to study in a com-
putationally efficient way sequence data within the framework provided by early HIV
infections. Earlier methods based on coalescent theory worked in more general settings
but, because they did not take advantage of the extreme homogeneity of our datasets,
were extremely inefficient in terms of computational time.
In this dissertation we propose a model of neutral, rapid population growth where
genetic diversity (mutations from the founder strain) arise and accumulate at random.
This scenario fits particularly well the early phase of the HIV infection, when the target
cell population is much larger than the viral one (hence the rapid exponential growth),
7
and the immune system has not yet started (thus allowing for random accumulation of
mutations).
In the first chapter we describe the model and show how we applied it to data from
acutely infected patients. We use the model to infer evolutionary parameters and predict
the time since the infection. We also describe the webtool available on the LANL server
[55], which is based on these methods. Applications to several datasets showed that our
methods perform well, and that time estimates correlate well with the patients’ clinical
data. Furthermore, as we will show, these methods are computationally efficient, which
is a very important feature now that the advent of deep sequencing [43] has led to out-
puts with tens of thousands of sequences. Currently, older methods based on coalescent
theory are not able to handle these large datasets.
In the second chapter we introduce recombination into the model and show that even
though it does not affect the behavior of the mean genetic diversity, it does indeed affect
the variance of the diversity. We calculate the effect of recombination on the model and
use a simulation to compare our theoretical results with simulated data.
Finally, in the third chapter we develop a statistic to compare genetic diversity across
patients. Again, we use a simulation to compare the performance of our statistic with an
existing one, and show that it is especially important for sample sizes typical of many
biological laboratories.
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C H A P T E R 2
EARLY HIV-1 EVOLUTION
2.1 Introduction
Population genetics has been applied to a vast number of organisms, from primates
to bacteria and virus. Combined with coalescent theory and phylogenetic methods, it can
retrace back in time the dynamics and evolution of species.
In this thesis, we develop an evolutionary model for HIV-1 during early infection, i.e.
within 30-40 days after the virus first entered the host. We test the genetic diversity of
early HIV-1 samples against a null model of neutral evolution. For this purpose we need
to find a suitable measure of genetic diversity. There are several measures of genetic
distances based on models of genetic drift or transition/transversion models. However,
the easiest to calculate, under the hypothesis of a neutral model, is the pairwise Ham-
ming distance (HD) distribution, which is defined as ”the number of allele differences
between all possible haplotype pairs” [4, 27]. Furthermore, it is model independent in
the sense that it doesn’t depend on the nature of the changes, but only on their number,
and hence it is always defined.
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2.2 The null model
To answer the questions mentioned in the Introduction, we develop a null model of
HIV-1 early evolution to be tested against samples from HIV-1 infected patients. Such
a model represents a null hypothesis of viral evolution under a neutral drift. We assume
that one unique genetic strain initiates the infection, which we call the founder strain or
most recent common ancestor (MRCA). Since it takes time before the host’s immune
response kicks in, and since during the early phase of the infection the viral popula-
tion is much smaller than the target cell population, we assume that viral evolution is
initially driven by exponential growth and random accumulation of mutations from the
founder [62]. Genetic diversity can also be achieved through recombination, which takes
place when two or more distinct strains infect one cell and give rise to new, recombined
genomes. However, when the viral population is sufficiently small with respect to the tar-
get cell population, the effect of recombination during the initial phases of the infection
should be negligible. We will discuss the effects of recombination in the next chapter.
Under these hypothesis, mutations from the founder strain accumulate randomly fol-
lowing a Poisson distirbution.
A phylogenetic tree is a tree-like diagram that graphically describes the evolutionary
process of a population sample. The present population lies at the leaves, and each node
represents a coalescent event, i.e. where the two branches below converge to a common
ancestor. In other words, a phylogenetic tree describes a process that starts at the root
and progresses in time as one moves towards the leaves. The root of the tree denotes the
MRCA of the sampled population. Given a sample of sequences, one can use a phylo-
genetic tree to reconstruct the intersequence evolution from the founder.
During rapid exponential growth in the absence of selection, and assuming the same
mutation rate across all lineages, small samples of sequences are likely to have evolved
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from the founder sequence following a star-like phylogeny, i.e., they all coalesce at
the founder [75], and the corresponding phylogenetic tree presents a star-like topology,
which is defined as a tree for which the length of the internal branches (between two
nodes) is small compared to that of the external ones (between a node and a leaf). There-
fore, there are two possible ways a given genetic sample from an HIV-1 early infection
can diverge from our null model: the pairwise HD distribution diverges from a Poisson
distribution; and (or) the phylogenetic tree does not present a star-like shape.
On the other hand, when the sample does satisfy our model’s assumptions, we can
use it to estimate the time since the MRCA, and compare it to the clinical data from the
patient. Early and acute infections can be timed clinically using the Fiebig staging sys-
tem (Figure 1), which is based on an orderly appearance of HIV RNA, HIV antigen and
antibodies against HIV in plasma [18]. Comparing the estimated MRCA with the Fiebig
stage provides insight on additional assumptions such as the value used for the model
parameters and whether or not it is legitimate to assume a mutation rate that’s constant
in time and across sites.
2.2.1 The HIV life cycle
HIV is a retrovirus, hence it uses RNA to encode its genetic material. A complex
of two proteins, gp120 and gp41, present on the viral surface enables the virus to fuse
with the target cell membrane. Once the virion enters a cell, the enzyme called reverse
transcriptase transcribes the viral RNA into double-stranded DNA, which then enters
the host genome. A viral genome integrated into the DNA of the host cell is called
provirus. The time from when the virus enters the target cell to when the first virions
start budding out has been estimated to last about 24 hours [42], although in some cases
the virus can lie dormant inside the cell for years. The infected cell will on average sur-
vive another 24 hours, during which it will produce a large number of new viral particles
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[7]. HIV is then rapidly cleared, roughly in 45 minutes [10], and on average, only be-
tween 6 and 10 virions will go on to successfully infect new cells [62]. The number of
virions that successfully infect new cells is called the basic reproductive ratio, usually
denoted R0. In epidemiology the basic reproductive ratio is defined as the average num-
ber of individuals that will get infected (secondary infection) from one infected subject
at the start of an epidemic when there’s no limit in the susceptible individuals.
In our approach, we make the following approximation: we reduce the two-population
model (where the two populations are the virus and the target cells) to a one-population
model by choosing to follow provirus instead of the actual virus. This is justified by
the fact that the lifetime of the virus outside the cell is negligible compared to the time
spent inside the cell (roughly 30-45 minutes versus 2 days). Hence, we choose as model
parameters the average life span τ of an infected cell to be 2 days, and R0 = 6, which is
a rounded value from the average number estimated from patient data [68]. By consid-
ering R0 to be constant, we make an approximation that holds during the viral growth
phase of the infection only. In fact, as the viral population grows, the target cell popu-
lation shrinks, resulting in less infected cells and a decline in the effective reproductive
ratio R, which is defined as the ratio between all offsprings at generation g+1 and gen-
eration g. A third important parameter in our model is the reverse transcriptase single
nucleotide substitution rate ε, i.e. the rate at which the HIV genetic sequences accu-
mulate single base substitutions. We use ε= 2.16×10−5 per base per generation, based
on experiments conducted by Mansky et al. [41], without counting gaps (deletions along
the genome), and we assume that it is constant throughout the genome.
2.2.2 The HD probability distribution under the null model
We assume a homogeneous infection in which the virus grows exponentially with no
selection pressure, no recombination, no occurrence of multiple mutations at the same
12
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Figure 5. Graphic of the Fiebig Staging based on blood tests and viral load.
Fiebig stage classification is based on the presence or absence of
the biological markers illustrated in the figure: each horizontal ar-
row represents the starting time when the specified test is expected
to yield positive results. We use this classification to compare with
our model’s timing estimates. The line in red denotes a typical viral
load curve, with peak viremia reached on average between the sec-
ond and third week after the onset of the infection. Colored areas
above each Fiebig stage represent model estimates (with 95% Con-
fidence Intervals) of maximum genetic diversity and corresponding
minimum days since the MRCA. This figure was created in R and
published in [34].
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site, and a constant mutation rate across positions and lineages. We measure genetic
distances using the Hamming distance, namely the number of positions at which any
two genetic strings differ. Assume also that all sequences evolve independently, and
let NB be the base pair length of each genome. Any randomly chosen sequence s that
has undergone exactly one replication cycle from the founder strain, s0, accumulates n
mutations from s0 with probability
P(n|g = 1) = Binom(n;NB,ε) (2.1)
where g = 1 denotes one generation away from the founder strain s0. In other words, the
probability distribution of the number of accumulated mutations after the first replication
cycle, is a binomial with size NB and probability ε (since each position is either mutated
or not; we will later approximate the binomial with a Poisson distribution). At generation
g = 2, the probability of having n mutations is the sum of all possible realizations of k
mutations occurring during the first replication cycle, and n−k during the second, for all
possible k’s. In other words, the probability is expressed as a convolution of binomials
P(n|g = 2) =
n
∑
k=0
Binom(n− k;NB,ε) Binom(k;NB,ε) = Binom(n;2NB,ε) (2.2)
where the second equality holds because the convolution of two binomials with same
probability p, is still a binomial with probability p and size the sum of the two sizes
[5]. In general, the above probability density does not coincide with the HD probability
distribution at generation g= 2 because of the possibility of multiple mutations occurring
at the same site. For example, if one of the n−k mutations in the second replication cycle
occurs in one of the k sites that mutated during the first replication cycle, the number of
mutations would still be n but the HD with the founder strain would be n−1.
In our model we neglect doubly mutated sites, i.e. sites mutating more than once, or
the same site mutating in sequences which have evolved independently. Both terms are
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O(ε2NBg), as we will show, and hence, given that for HIV ε∼ 10−5, and the HIV genome
is about 103 bases long, our approximation is still valid within the first 30-40 generations
since the infection. To see this, consider that the probability of a site mutating no more
than once after g replication cycles is given by
P = (1− ε)g+g ε(1− ε)g−1 (2.3)
and therefore, the probability of having at two or more mutations in at least one of the
NB base pairs, expanding in ε and neglecting terms of O(ε3), is
Q = 1−PNB ≈ 12 NB g(g−1)ε
2 for ε<< 1. (2.4)
In [34], we applied our model to HIV-1 genetic segments that express the env gene,
a region that is about 2,600 base pairs long. For NB = 2,600, and for ε = 2.16× 10−5,
one finds that even at g = 50, Q < 0.0015. Fifty replication cycles correspond to ap-
proximately 75-100 days into the infection, and all ”early samples” we typically apply
the model to fall below this threshold. Therefore, throughout this work, we will neglect
the occurrence of multiple mutations at the same site, and we will make the following
approximation for the HD probability distribution at generation g
P(HD = d|g) = Binom(d;gNB,ε)+O(g2ε2NB), (2.5)
where, in what follows, we will leave the O(g2ε2NB) correction implicit.
Finally, notice that thanks to Chebyshev’s inequality (see Appendix A, Claim A.1),
we have that at any generation g the probability of having more mutations than the avail-
able sites NB is indeed negligible.
2.2.3 Star-like phylogeny and convolution
The evolutionary null model that we have devised predicts that a small sample of
sequences taken from the population will follow a star-like phylogeny, and the sampled
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sequences coalesce back at the founder [75]. This means that the intersequence HD dis-
tribution is indeed the self-convolution of the HD distribution obtained comparing each
sequence to the founder strain. To avoid confusion, we will denote HDI the interse-
quence HD, and HD0 the distances from the founder. We have shown that
P(HD0 = d|g) = Binom(d;gNB,ε) (2.6)
Because we are neglecting multiply mutated sites, it follows that under a star-like phy-
logeny, any two sequences s1 and s2 will be such that HD1[s1,s2] = d if and only if
HD0[s1,s0] = k and HD0[s2,s0] = d− k for k between d and 0 (where like before, we
denote s0 the founder strain). Hence
P(HDI = d|g) = ∑dk=0 P(HD0 = k|g)P(HD0 = d− k|g) =
= ∑dk=0 Binom(d− k;gNB,ε) Binom(d;gNB,ε) = Binom(n;2gNB,ε)
(2.7)
Here, we are implicitly assuming that the two sequences s1 and s2 have evolved indepen-
dently from the initial founder strain, which hence is the MRCA of the two sequences.
This may not be the case, as it is conceivable that the MRCA is not the founder strain but
instead another sequence that evolved from it. Assuming that the population grows expo-
nentially as Rg0, we now show that the probability of such an event decays exponentially
with generation time. Suppose that the sequence s1 is randomly chosen after g replica-
tion cycles. As shown in Figure 2.2.3, for every integer a between 0 and g, Rg−a0 − 1
sequences out of the remaining Rg0− 1 coalesce with s1 exactly g− a generations back.
Therefore, the probability of picking a sequence s2 that coalesces g−a generations back
instead of g is given by
P(MRCA[s1,s2]≤ g−a|g) =
Rg−a0 −1
Rg0−1
≈ O(R−a0 ) (2.8)
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*
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a=0
a=1
a=2
a=3
S0
Figure 6. An example on how the MRCA between two sequences may not co-
incide with the founder strain. The sequence s1 (denoted with a star)
coalesces back at the MRCA with the blue leaves, but earlier with
the red leaves. By generalizing the above tree, one can see that as
the generations increase, the probability that two randomly sampled
sequences do NOT coalesce at the founder strain decreases exponen-
tially.
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For example, for a sample that is 2 weeks into the infection, i.e. at least 5 replication
cycles from the founder strain, and before any selection pressure, given R0 = 6 and g= 5,
one gets that the probability of any 2 sequences to coalesce 1 generation away from s0
is 0.167, 0.028 to coalesce 2 generations away, and 0.0045 for 3 generations away. For
g ≥ 5, the probability of coalescing more than 3 generations away from the founder is
less than 0.005. However, even when g is quite large, there is still a 17% chance that the
calculated MRCA of any two randomly sampled sequences, is in fact 1 generation away
from the actual founder, a 3% chance that it is 2 generations away and a 0.5% chance
that it is 3 generations away.
Given a sample of N0 sequences, and neglecting correlations between pairs, we get
that the probability of having two sequences in the sample coalesce at a generation a 6= 0
is approximately
N0(N0−1)
2
Rg−a0 −1
Rg0−1
. So one can see that while it still decays expo-
nentially, the larger the sample the higher the likelihood of diverging from a star-like
phylogeny.
Equation (2.7) provides us with a means to check whether or not the phylogeny of a
low-diversity HIV-1 sample is indeed star-like. Namely, given a sample of N sequences
s1, ...,sN , we first construct the consensus sequence s0 by taking, at all positions, the
most frequent nucleotide. In low-diversity samples that do comply with the assumptions
in our model, s0 is uniquely defined, and we can assume it to be the founder strain (we
will later discuss what this assumption implies). Once we have s0, we can compute the
HD0 frequency counts X0,X1, ...,Xm, where Xi is the number of sequences s such that
HD0[s,s0] = i.
For j = 1, ...,2m, let Y j be defined as follows
Yj =
1
2
j
∑
i=0
XiX j−i− 12 δ j, j−iXi (2.9)
where δx,y is the Kroenecker delta.
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Claim 2.1. For j = 1, ...,2m, let Y˜j be the number of sequence pairs (s1,s2) in the sample
such that HDI[s1,s2] = j. Let Yj be defined as in equation (2.9). If the sample follows a
star-phylogeny, then, for all j’s, we have that, Y˜ j = Yj.
Equation (2.9) follows from the fact that, if we assume star-phylogeny, then all the
pairs in HDI = 0 with each other will be the all the unique pairs from the sequences that
are in HD0 = 0 with the consensus, and these are exactly
1
2 X0(X0−1). Similarly, Y1 will
be all pairs between X0 and X1, which are X0X1, and so on.
2.3 Two simplified models: synchronous and asynchronous
In the attempt of describing the initial viral evolution, one can make some first simple
assumptions and deduce the infected cell population at all times. Let Ig(t) be the number
of cells at time t that have undergone exactly g replication cycles from the founder strain.
Every two sequences s1 and s2 in Ig(t) are such that HD[s1,s2] = d with probability
Binom(d;2gNB,ε). Then the total intersequence HD probability distribution, over all
groups Ig(t), as a function of time, is given by
P(HDI = d| t) =
∑g Ig(t)Binom(d;2gNB,ε)
∑g Ig(t)
(2.10)
Hence, at any given time t the mean intersequence Hamming distance is given by
E[HDI](t) =∑
d
dP(HD = d| t) =∑
d
∑g Ig(t)Binom(d;2gNB,ε)
∑g Ig(t)
(2.11)
and because the two summations can be interchanged, one gets
E[HDI](t) = 2εNB
∑g gIg(t)
∑g Ig(t)
(2.12)
Similarly
Var[HDI](t) = 2ε(1− ε)NB
∑g gIg(t)
∑g Ig(t)
(2.13)
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Therefore, we need to compute Ig(t) and
∑g gIg(t)
∑g Ig(t)
.
2.3.1 Synchronous model
We first assume that each cell, once infected, survives for exactly a time τ, at the
end of which it bursts out all newly generated virions, of which exactly R0 go on and
successfully infect new cells almost instantaneously. We will call this the synchronous
model, as it predicts that all cells get infected synchronously at regular time intervals of
length τ. All cells of any given generation g are born at the same time gτ and all die at
time (g+1)τ, and there’s exactly I0R
g
0 of them, where I0 is the number of infected cells
at time t = 0 (which we assume to all carry identical genomes). So, at any given time t
Ig(t) =
 I0R
g
0 if gτ≤ t < (g+1)τ
0 otherwise
(2.14)
Since all cells are infected and die at the same time, all terms in
∑g gIg(t)
∑g Ig(t)
are null except
the one for g =
⌊ t
τ
⌋
. Therefore
E(HDI)(t) = 2εNB
⌊ t
τ
⌋
(2.15)
Similarly
Var(HDI)(t) = 2ε(1− ε)NB
⌊ t
τ
⌋
(2.16)
The synchronous growth rate, in the logarithmic scale, is
ρs = logR0
Ig+1(t)
Ig(t)
= logR0
Rg+10
Rg0
= 1 (2.17)
Hence, the daily growth rate is
ρs
τ = 0.5, where we have used τ = 2 since the average
survival time of an infected cell is 2 days [42].
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2.3.2 Asynchronous model
In the synchronous model we assume that the infected cell produces all the virions
in one cellular burst. That may very well not be the case, as it may in fact happen that
virions bud out of the cellular surface a few at a time. This motivates our asynchronous
model, where we assume that each infected cell infects α cells after a time τa, and an-
other γ cells at time 2τa after its infection, where α+γ= R0. Clearly this is another gross
approximation, though one can see that once we understand this particular scenario, the
generalization to n cell bursts easily follows and, by the limit, the continuous case as
well. For the time being we do not assume τa = τ, and we will later discuss how τa is
related to the mean survival time of an infected cell. In contrast to the the synchronous
model, now we have that at any given time t, the surviving infected cells have under-
gone a minimum of
⌈ t
2τa
⌉
replication cycles, and a maximum of
⌊ t
τa
⌋
. In other words,
Ig(t) 6= 0 for
⌈ t
2τa
⌉
≤ g≤
⌊ t
τa
⌋
.
For simplicity, let n =
⌊ t
τa
⌋
. We show in Appendix A (Claim A.2) that
Ig(t) = I0αn
( γ
α2
)n−g g
n−g
 for g = ⌈n2⌉ , ...,n, and 0 otherwise. (2.18)
In the same appendix (Claim A.5) we also show that the corresponding HDI probability
distribution is given by
P(HDI = d|n) = 1Fn
n
∑
g=
⌈n
2
⌉
 g
n−g

 2gNB
d
( γα2)n−g εd(1− ε)gNB−d (2.19)
where
Fn =
(1+ϕ)n+1−(1−ϕ)n+1
2n+1ϕ and ϕ=
√
1+4
γ
α2 . (2.20)
Claim 2.2. In the asynchronous model, for every n there exists a λn such that P(HDI|n)≈
Pois(λn)+O(ε2) and hence, like in the synchronous model, up to second degree terms
in ε, the intersequence HD’s follow a Poisson distribution.
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The proof of Claim 2.2 is given in Appendix A, where it is shown that
λn = n
1+ϕ
ϕ +
1−ϕ
ϕ2 . (2.21)
It follows that the probability distribution in equation (2.19) has mean µn = 2λnεNB and
variance σ2n = 2λnε(1− ε)NB.
In order to compute the duration of the time step τa in the asynchronous model, we
impose that the growth rate in the two models be equal. This is motivated by the fact that
the generation time τ is a biological quantity and hence should not depend on the model.
Rather, we fix the model parameters based on the biological quantities τ and R0.
We have seen that in the synchronous model, the log daily growth rate is 0.5. As-
suming R0 1 and I0 = 1, at any given time t, the total population of infected cells is
(see Appendix A)
N(n) =∑
g
Ig(n) = Fnαn (2.22)
The logarithmic growth rate is given by
ρa = logR0
N(n+1)
N(n) = logR0
(
α
Fn+1
Fn
)
. (2.23)
For n 1, using the fact that 0 <1−ϕ1+ϕ< 1, one can see that
Fn+1
Fn
≈ 12(1+ϕ). (2.24)
By imposing that the daily growth rate in the two models be equal, we get
ρa
∆τa
∆days =
1
2 (2.25)
hence
τa = 2ρa ≈ 2logR0
(
α
1+ϕ
2
)
(2.26)
When we use the aforementioned values of R0 = 6 and ε= 2.16×10−5 one gets τa = 1.5
days, which is what had been used to analyze the homogeneous patients in [34].
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2.4 Computing the time since the MRCA
We have described two possible models of HIV infection and evolution. How can we
use them to make useful inferences about the way the virus has evolved into the host?
As stated earlier, in a homogeneous infection we expect the intersequence Hamming
distances to follow a Poisson distribution. Therefore, given a sample of N HIV-1 ge-
netic sequences sampled in the first few weeks since the infection, we can calculate the
pairwise Hamming distance frequency counts Y0,Y1, ...,Yn. Here, for i = 1, ...,n, Yi is the
number of pairs whose relative Hamming distance (number of bases at which the two
sequences differ) is exactly i. To these frequency counts we fit a Poisson distribution
with parameter λ. As a function of λ, the log likelihood function is given by
LL(λ) = Log
(
(Y0+...+Yn)!
Y0!...Yn!
n
∏
i=0
[
e−λλi
i!
]Yi)
(2.27)
Minimizing the above one finds
λ= ∑ iYi∑Yi
(2.28)
which is exactly the mean of the intersequence Hamming distances. Once we have the
parameter λ of the best fitting Poisson distribution, the next question is whether or not
our assumption of the frequency counts following a Poisson is met. In order to test for
that, we use a χ2 goodness of fit test for dependent data cells (see Appendix B) because
the pairwise Hamming distances are clearly not all independent.
For samples that yield a P-value of 0.05 or above (and hence show no evidence of
significant divergence from a Poisson distribution), we use the estimated parameter λ to
compute the number of generation since the MRCA. In particular, using Eq. (2.15) and
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(2.21), one derives the number of generations gMRCA
gMRCA =

λ
2εNB
synch. model
ϕ
1+ϕ
(
λ
εNB
− 1−ϕϕ2
)
asynch. model
(2.29)
2.5 Poisson Fitter: a webtool for the analysis of homogeneous ge-
netic samples
In [21] we describe Poisson Fitter, a webtool [55] we devised to automize the anal-
yses described above. The code implements a jackknife method to calculate the standard
deviation on the parameter λ and derive confidence intervals on the number of gener-
ations. Such estimates come with the usual caveat that in reality parameters like the
eclipse phase or the mutation rate vary greatly across patients [T. Bhattacharya, work in
progress]. However, we have seen in [34, 1] that overall our estimates are well corre-
lated with the patients’ clinical data such as Fiebig stage [18]. The tool allows the user
to provide their own estimate for the mutation rate, enabling adjusting between the time
since the MRCA and the available clinical data.
All the parameters explained in the previous sections are computed and included in
the output table called “Log Likelihood - Estimated Parameters.” This comprises, for
each sample: the number of sequences in the sample, the mean and maximum pairwise
HD, the mean of the best fitting Poisson distribution, the corresponding time since the
MRCA, and the goodness of fit P-value. It is important to notice that when the sample
meets our model’s assumptions, the mean of the best fitting Poisson distribution is in fact
the mean pairwise HD of the sample. A second table, called “Convolution Estimates,”
provides the observed HD frequencies and the estimated ones calculated using equation
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(2.9). A more detailed explanation of the parameters is provided in the Explanation file
on the tool web page.
Figure 7. Screenshot of our webtool, Poisson Fitter.
Figure 4 shows the graphics obtained by analyzing a fragment of the NEF HIV-1 gene
(169 base pairs) from patient CH40 [34, 19]. The data have been published [19] and sub-
mitted to the NCBI Sequence Read Archive (http://www.ncbi.nlm.nih.gov/Traces/sra)
under accession number SRA020793. This sample was obtained through deep sequenc-
ing [43, 71] and yielded a little over 4,000 sequences, though our tool can easily handle
ten times as many sequences because it works only with counts of pairwise distances.
The left panel in Figure 4 shows the pairwise HD frequency counts (black), the best fit-
ting Poisson distribution (blue), and the expected counts if it were a star-phylogeny (red)
on a logarithmic scale. The fact that the red line and the black line are almost indistin-
guishable confirms that the sample follows a star-like phylogeny. Because the Poisson fit
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is very sensitive to deviations in the upper tail of the distribution, the tool outputs graph-
ics in the logarithmic scale whenever the sample size is above 100; this helps visualize
possible deviations at the higher distances. Though the values are discrete, lines are used
for better visualization. In the right panel a histogram of the frequency counts is shown
together with, in red, the best fitting Poisson distribution. In this case the sample yielded
a good fit (P = 0.981) and a time to MRCA of 34 days 95% CI= (31,38).
Figure 8. Example of output graphics for a typical 454 sample that conformed
to the model [19]. Pairwise HD frequency plots on a logarithmic scale
(black, left panel), together with the best fitting Poisson (blue) and the
theoretical counts expected if the sample were to follow a star-like
phylogeny. The right panel shows the pairwise HD histogram and
the best fitting Poisson distribution (red). In the legend we report the
GOF P-value (P= 0.981), the estimated days since the infections (d =
34(31,38)), and the number of sequences in the sample (N = 4046).
2.6 Discussion
We applied the synchronous and asynchronous models to characterize early homo-
geneous infections and estimate the time since the MRCA. We have first used the type
of analyses described above in [34] and, subsequently, in [80, 1]. We concluded that in
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HIV-1 heterosexual transmissions there exists a bottleneck that results in roughly 80% of
the infections being homogeneous, i.e. initiated by a single viral strain. This motivated
the webtool presented in [21], which allows for the analysis of homogeneous genetic
data, not only of HIV, but also of genetic strains with similar evolutionary patterns (as
for example the hepatitis C virus).
Due to the availability of early samples taken at multiple time points from acute HIV
subjects, we now know that the viral population grows exponentially during the early
phases of infection [62], prior to the onset of the host immune response or significant
target cell depletion. Given this simple setting, our goal is to clearly distinguish in-
fections that were initiated by a single strain (homogenous infection) from those where
multiple strains entered the host. Furthermore, for those cases where we are able to de-
termine that the infection was indeed homogenous, we seek to estimate the time since the
most recent common ancestor (MRCA) given a sample of genetic sequences. In contrast
to coalescent and Bayesian inference methods (e.g., BEAST [14]), which are based on a
simulation of genealogies, we do not simulate the genealogical history of the observed
sequences, but rather follow the diversity structure of the entire viral population. While
in most settings a forward simulation is not attainable (hence the use of coalescence),
our approach becomes not only feasible but extremely simple to realize when model-
ing a homogeneous infection growing exponentially for a small number of generations
from the transmission bottleneck. The increased efficiency of the algorithm (which runs
within minutes instead of hours) facilitates the analysis of samples from a large number
of subjects [34] and enables the application to massive new data sets that are currently
being gathered using deep sequencing [43], for which Bayesian methods are not feasible.
Currently, our tool is the only one available able to perform these kind of analyses on
such large datasets. We have successfully tested our tool in both cases, i.e., hundreds of
patients and tens of thousands of sequences. These methods are robust against violations
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of assumptions that do not strongly affect overall diversity. Quantities like the time since
the MRCA, when computed by our tool, yield virtually identical results [39, 34] to those
computed by the coalescent or Bayesian methods [21].
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C H A P T E R 3
RECOMBINATION
3.1 Introduction
Genetic recombination takes place when a newly constructed nucleic acid molecule
arises from multiple template strains. The initial molecules are called the parental
strains, and the new one is called a recombinant. Recombination events in HIV-1 have
been shown to take place [47, 61, 81] as a result of multiple infections [6, 9, 33, 40].
When two or more virions infect the same cell, the two distinct RNAs can be packaged
into a new virus. A cell infected with a recombinant virus will contain genetic material
from both parental strains. A number of studies have hypothesized the HIV recombi-
nation rate to be several times larger than its mutation rate [32, 40, 65, 70], and that
recombinants reach fixation and undergo a rapid expansion in the population, thus rep-
resenting an evolutionary shortcut [58].
Hence we introduce recombination in the evolutionary models we have developed so
far, and study how this affects the change in Hamming distance with time. Previously,
such studies have been conducted in the context of anti-retroviral therapy [2, 20, 37, 45,
72] and with regards to its effects on immunological responses [44]. In [72] the authors
use a simulation to study the effects of recombination on the changes in mean Hamming
distance with time. However, in all the work cited above, it is assumed that the host’s
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immune response plays a major role in defining the fitness of the viral strains. In this
chapter we stick to our initial model of exponential viral growth with no selection pres-
sure from the environment. Under this scenario, we show that recombination does not
affect the linearity in mean HD growth.
3.2 Probability Distribution in the presence of recombination
We start with the exact same scenario described in Chapter 1: a single infecting strain,
no selection, and an exponentially growing viral population. We neglect doubly mutated
sites. Like before, let the mutation rate be ε. To allow for the possibility of multiple
strains infecting the same cell, we introduce a recombination probability 0 < ρ < 1. As
a simplification, during the infection of a cell, we let each viral strain either undergo a
mutation event or a recombination event, but not both.
!"#$%&'(
)$*+,-.%"%&(
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Figure 9. Schematic of a recombination event: two parental strains (depicted
in red and blue, respectively), recombine at a position θ. As a result,
the recombinant inherits the first base up until the θ−1 one from the
blue parent, and the rest from the red parent.
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We assume ρ is constant in time and, for simplicity, we also assume that the parental
strains recombine at a single position θ, which is a uniformly distributed random variable
between 0 and the length NB of the genome (Figure 9). With these assumptions, the HD
probability distribution at time t+dt is such that
P˜(HD = d; t+dt) = (1−ρ)Pε(HD = d; t+dt)+ρPρ(HD = d; t+dt) (3.1)
where Pε and Pρ are the probability of a string being at distance d after a replication
or a recombination event respectively. Suppose that Pρ has mean µρ and variance σ2ρ.
Similarly, we let µε and σ2ε denote the mean and variance of Pε. Then
µ˜(t) = E(HD|t) = (1−ρ)µε(t)+ρµρ(t) (3.2)
and
σ˜2 =Var(HD) = σ2ε+2 ρ µε(µε−µρ)+ρ(µ2,ρ−µ2,ε)−ρ2(µε−µρ)2 (3.3)
where µ2,ε and µ2,ρ indicate the second moments. When ρ= 0 we get σ˜2 = σ2ε and when
ρ= 1, σ˜2 = σ2ρ. Notice also that when µε = µρ one has
σ˜2(t) = σ2ε(t)+ρ (µ2,ρ(t)−µ2,ε(t)) (3.4)
In what follows, whenever time is clear from the context, we will omit the variable
t. We already know what happens when cells undergo a replication, i.e. mutations arise
with a probability
Pε(d; t+dt) =
d
∑
k=0
P˜(d− k; t)Pm(k;dt) (3.5)
where Pm(k;dt) is the probability of having k mutations appear in a unit time interval
dt. Assuming the generation of new mutations during the time dt is independent of how
many mutations are present at time t, we can use the fact that cumulants of a convolution
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of independent variables are additive. Let dλ be the mean of the distribution Pm in the
time interval dt (for example, in a discrete, synchronous model, it would be the mutation
rate times the sequence length). Therefore, omitting O(dλ2) terms,
µε(t+dt) = µ˜(t)+dλ
σ2ε(t+dt) = σ˜
2(t)+dλ
µ2,ε(t+dt) = µ˜2(t)+(1+2µ˜(t))dλ
(3.6)
In order to understand Pρ we need a bit more work, to which we dedicate the next
few sections.
3.3 Probability distribution in the presence of recombination alone
In order to understand how recombination affects the HD probability distribution,
we devise a simulation based on the previously described synchronous model. As un-
derlying assumptions, we use an infinite site model where no site is mutated more than
once. We start with N0 identical sequences at generation g = 0. At each later generation
we resample (with replacement) N0R
g
0 sequences from the previous population of size
N0R
g−1
0 , where R0 is the basic reproductive ratio. We start with an initial population of
sequences N0, which we assume have all evolved from an initial strain s0.
3.3.1 The effect of genetic drift
Under this scenario, the first thing we need to understand is the genetic drift, a
change in the population frequency of a gene allele. The effect arises from the fact that
every new generation is a sampling of the prior one (biologically, this corresponds to the
fact that not every infected cell is able to infect a new generation of cells), and, as such,
the resampling can randomly be skewed in the same direction over multiple generations.
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The effect, which is a finite sample effect, is larger the smaller the population, and it can
eventually lead to either the fixation of the allele or its extinction. We now propose to
calculate how genetic drift affects the probability distribution of the Hamming distances.
Assuming a synchronous model, at any generation g, the population size is given by
Ng = R
g
0N0. Suppose that at generation g = 0 the HD has mean µ0 and variance σ
2
0. At
any given generation g the HD sample mean m and the estimated variance s2 are given
by
m(g) = 1Ng∑HDx (3.7)
and
s2(g) =
Ng
Ng−1
(
1
Ng∑HD
2
x−m(g)2
)
(3.8)
where HDx is the Hamming distance from the initial strain s0 at position x = 1, ...,NB,
and NB is the total length of the sequences. From generation g to the next, both m and
s2 are random variables from a distribution with expectations given by respectively the
first and second cumulants of the HD distribution at generation g (since for now we are
assuming all that is happening from one generation to the next is a bootstrap). If there is
no recombination nor mutation events,
E(m(g+1)) = µg = µ0 (3.9)
and
E(s2(g+1)) = κ2(g) =
1
Ng
∑
x
(
HDx− 1Ng∑y
HDy
)2= Ng−1Ng s2(g) (3.10)
3.3.2 Same initial Hamming distance
Let us now allow the sequences to recombine. We first look at a simplified sce-
nario in which all initial N0 sequences have identical HD0 = d from the initial strain s0.
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Like before, we let NB be the length of the sequences, and x be any position between
1 and NB. We assume NB  1 (infinite site assumption). If the mutated positions are
uniformly distributed, then any given site x is mutated with probability dNB
. Let µx(t)
be the average number of mutations at the x-th site at time t. Then, obviously, at time
t = 0, µx(0) =
1
N0
. We assume a simple model of exponential growth under recombina-
tion only: at each generation step a recombination position θ is drawn randomly from
a uniform distribution, with θ = 0, ...,NB, where the two parental strings divide and re-
combine. If θ= 0, then the recombinant is exactly the first sequence, whereas if θ= NB,
the recombinant is the second sequence. At every generation, all that is happening at
position x is a boostrap of mutated sites, which we have seen from the previous section
does not change the mean HD, while the expected variance at position x will shrink by a
factor
Ng−1
Ng
. In other words, for all g > 0, µ(g) = d, and
s2x(g+1) =
Ng−1
Ng
s2x(g) (3.11)
To understand how the covariance σx,y between any two sites x and site y changes,
we split the set of sequences in two groups: the ones derived from two parent sequences
which recombined somewhere between x and y, and those derived instead from a recom-
bination point outside x and y. Let N1 be the number of sequences in the first group,
and N2 the number of sequences in the second group, so that N1+N2 = Ng (when clear
from the context, we omit the dependency in g for simplicity of notation). We define
wi = E
(
Ni
Ng
)
and κi1x and κ
i
11 the cumulants of the Hamming distance in the i-th group
at a fixed generation g. Given positions x and y along the genome, an estimator of the
covariance is given by
sxy(g) =
1
Ng−1 ∑s∈Ng
(dx− x¯)(dy− y¯) (3.12)
where Ng is the total number of sequences at generation g, dx and dy are the Hamming
distances at positions x and y respectively, and x¯ and y¯ their means. By splitting the
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summation over sequences in N1 and sequences in N2, one gets
sxy(g) = ∑
i=1,2
Ni−1
Ng−1si+ ∑i=1,2
Ni
Ng−1(x¯i− x¯)(y¯i− y¯) (3.13)
where si is the variance over subset Ni, and x¯i and y¯i are the means at positions x and y
respectively within group Ni. Taking expectations on both sides of the above equation,
one obtains
E(sxy)|g+1 = ∑i=1,2 wiκi11+
Ng+1
Ng+1−1
[
∑i=1,2 wiκi1xκ
i
1y−
−(∑i=1,2 wiκi1x)(∑ j=1,2 w jκ j1y)] .
(3.14)
Notice that the first bit is the weighted average of the κi11’s, and the second term is the
weighted covariance between κi1x and κ
i
1y. Now, we’ve seen that κ
i
1x = κ
i
1y = d at all
times, whereas with the above definitions of N1 and N2, we get κ111 = 0 (the recombina-
tion position separates x and y and hence the number of mutations at each site become
independent variables), whereas κ211 =
Ng−1
Ng
E(sxy). Furthermore, w2 =
(
1− y−xNB+1
)
.
Therefore, when averaging over simulation runs, one gets
E(sxy)(g+1) =
(
1− y−xNB+1
) Ng−1
Ng
E(sxy)(g) (3.15)
In particular, given g > 0, and a sequence s, let HDs(g) = x1(g)+ ...+ xNB(g) be the
total number of mutations of sequence s at generation g, which for simplicity we will
denote Xg. From our assumptions, X0 = d. The sample mean at generation g is
X¯g =
NB
∑
i=1
E(xi) =
NB
∑
i=1
µi = d (3.16)
and therefore does not change with time. However, over multiple runs,
Var(X¯g) =
NB
∑
x=1
σ2x(0)+2∑
x<y
(
1− y−xNB+1
)g
σx,y(0) (3.17)
We therefore need to compute σ2x(0) and σx,y(0), and then use equations (3.11) and
(3.15) recursively to compute the variance and covariance at any given position along
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the genome. We are still assuming that at the initial time point all N0 sequences have
a fixed Hamming distance d, and that the d mutated sites are drawn from a uniform
distribution between the first position and the last with probability 1NB
. Because we know
that ∑xi = d, we have NB−1 degrees of freedom, and therefore the moment generating
function M(β) of the probability distribution of the Hamming distances at positions x1
through xNB−1 is given by
χ(β) = log M(β) = d log
[
1
NB
(
1+
NB−1
∑
i=1
eui
)]
, (3.18)
where β= (u1, ...,uNB−1) is a vector of variables. Taking the first and second derivatives
at 0, we find
σ2x(0) =
∂2χ
∂u2x
|β=0 =
∂χ
∂ux
[
deux
1+∑y euy
]
|β=0 = d 1NB
(
1− 1NB
)
(3.19)
and
σx,y(0) =
∂2χ
∂uxuy |β=0 =
∂χ
∂ux
[
deuy
1+∑k euk
]
|β=0 =− dN2B
. (3.20)
One can verify that the above is correct by checking that the total initial variation is
s2(0) =
L
∑
x=1
σ2x(0)+2 ∑
x<y≤NB
σx,y(0) = 0 (3.21)
since all sequences have the same initial distance d. At generation g > 0, by summing
over all positions, we get the expression for the total HD variance:
s2(g) = d
(
1− 1NB
)
−2 d
N2B
∑x<y≤NB
(
1− y−xNB+1
)g
∏g−1j=0
N j−1
N j
=
= d
(
1− 1NB
)
−2 dg+2
[(
NB
NB+1
)g−1
+O(N−1B )
]
∏g−1j=0
N j−1
N j
(3.22)
where to compute the above we have used
2
NB−1
∑
x=1
NB
∑
y=x+1
(
1− y−xNB+1
)g
=
2
(NB+1)g
NB−1
∑
k=1
k(k+1)g =
Ng+1B
(g+2)(NB+1)g−1
+O(NB).
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3.3.3 Variable initial Hamming distance
Using the same notation as above, we now let the initial Hamming distance d be
randomly drawn from a distribution P(d) with mean µ0 and variance σ20. For every
position x, the probability of observing n mutations at that site is
P(x = n) =∑
d
P(d)P(x = n|d). (3.23)
So at the x-th position, the moment generating function is
Mx(t) =∑
x
P(x) etx =∑
d,x
P(d)P(x|d) etx =∑
d
P(d)mx,d(t) (3.24)
where mx,d(t) is the moment at the x-th position for all sequences with initial Hamming
distance d. To compute the mean at position x then
dMx
dt |t=0 =∑
d
P(d)
dmx
dt |t=0 =∑
d
d
NB
P(d) =
µ0
NB
(3.25)
and hence the total mean is µ0 at all times. Applying the same logic to compute σ2x(0)
and σxy(0) we find
σ2x(0) =
d2Mx
dt2 |t=0 =
NB−1
N2B
µ0+
1
N2B
σ20 (3.26)
and
σxy(0) =
∂2Mxy
∂t∂u |t=0,u=0 =
1
N2B
(
σ20−µ0
)
(3.27)
Like before, it’s easy to see that summing the above two equations over all positions,
one gets the initial variance σ20. Since the first moments are still the same across posi-
tions, the equations computed in the previous section still hold, and the only change is in
the initial conditions. Inserting those in (3.11) and (3.15) one gets
s2(g) =
NB−1
NB
µ0+
1
NB
σ20+2
σ20−µ0
N2B
∑x<y≤NB
(
1− y−xNB+1
)g
∏g−1j=0
N j−1
N j
=
=
NB−1
NB
µ0+
1
NB
σ20+2
σ20−µ0
g+2
[(
NB
NB+1
)g−1
+O(N−1B )
]
∏g−1j=0
N j−1
N j
(3.28)
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3.4 Recombination and Mutations
Equation (3.14) can be generalized to an indefinite number of partitions Ni such that
∑i Ni = Ng, the total number of sequences at generation g. Fix positions x and y and
choose N1 to be the number of sequences derived from a recombination event that sepa-
rated positions x and y; N2 the number of sequences derived from either a recombination
event that did not separate positions x and y, or from a division with no mutation; and, fi-
nally, denote Nk, with k = 3,4 or 5 the number of sequences such that only the x position
has mutated, only the y position, or both, respectively. Like before, let wi = E
(
Ni
Ng
)
.
Assume that mutations happen with a rate ε (per site, per generation), and recombination
events happen with a rate ρ. Given this set-up, we notice that
E(w j) =

y−x
NB+1
ρ if j=1
(
1− y−xNB+1
)
ρ+(1−ρ)(1− ε) if j=2
ε (1−ρ) (1− ε) if j=3 or 4
(1−ρ)ε2 otherwise.
(3.29)
Let ξ= ε(1−ρ). Carrying out similar computations as sketched in the previous section,
one notices that, for every position x and y
µx(g+1) = µx(g)+ξ (3.30)
s2x(g+1) =
Ng−1
Ng
s2x(g)+ξ(1−ξ) (3.31)
sxy(g+1) =
(
1−ρ y−xNB+1
) Ng−1
Ng
sxy(g)−
Ng+1
Ng+1−1ξ
2+
+ξ
(
ε− 1Ng+1
)
−2νξ2 1−εNg+1
(3.32)
38
From equation (3.30) we derive the fact that even in the presence of recombination,
the mean Hamming distance still grows linearly with the number of generations as in the
scenario without mutations [39], but the growth rate is diminished by a factor ρ:
µ(g) = NBε(1−ρ)g+µ0, (3.33)
which follows from assuming that at every generation a sequence either undergoes a
recombination event or a mutation. Assuming, like in the preceding sections, that we
start off with a fixed number of sequences whose Hamming distances follow a distribu-
tion with mean µ0 and variance σ20, given positions x and y, the total initial variance at
position x and covariance between x and y are still given by equations (3.26) and (3.27).
3.5 Simulation results
As mentioned before, we use an infinite site model where no site is mutated more
than once. We start with N0 identical sequences at generation g = 0. At each later gen-
eration we resample N0R
g
0 sequences from the previous population of size N0R
g−1
0 . For
a fixed mutation rate ρ and mutation rate ε, we first draw the number of recombination
events from a binomial distribution with probability ρ. Subsequently, for each sequence
s in the new generation population, if s is a recombinant, we draw the two parents and a
split position θ and form s as the recombinant child. Else, we randomly draw a number
of mutated positions from a Poisson distribution with mean εNB where NB is the length
of the sequences. If Xs(g−1) is the HD of a sequence s at generation g−1, and d is ran-
domly drawn from Pois(λ= εNB), then Xs(g) = Xs(g−1)+d, where the exact positions
where these mutations take place are drawn randomly from a uniform distribution.
Because of computational limitations, we limit the number of generations to 6-8 and
simulate 10,000 sets, then average the HD mean and variance and compare to the theoret-
39
ical results discussed in the previous sections. Simulation results for different choices of
parameters ρ and ε are illustrated in the figures that follow, where the simulation is repre-
sented by the black dots, and the theoretical results by the dashed red line. We show the
two extremes of recombination only and no recombination (ρ = 0 and ρ = 1), and also
show one possible scenario with ρ= 0.5 and a mutation rate of ε= 0.0025 per base per
generation cycle (this particular value is considerably larger than the HIV-1 mutations
rate found in [41] but we chose a larger value in order to speed up the accumulation of
mutations in the simulation). In all runs, at generation g = 0 we have N0 = 100 and each
sequence s has HD ds randomly drawn from a Poisson distribution with mean λ = 10.
The code was written in R [57].
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Figure 10. Comparison between theory and simulation for an exponentially
growing population with ρ = 0 (no recombination) and ε = 0.003.
Mean and variance of the HDs are averaged over 10,000 runs. The
simulation is represented by the black dots, and the theory by the
dashed red line. Confidence intervals (±1.96 times the standard de-
viation over runs) are represented by vertical gray segments (very
small in the above panels).
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Figure 11. Comparison between theory and simulation for an exponentially
growing population with ρ = 1 and ε = 0 (recombination only) .
Mean and variance of HD are averaged over 10,000 runs. The simu-
lation is represented by the black dots, and the theory by the dashed
red line. Confidence intervals (±1.96 times the standard deviation
over runs) are represented by vertical gray segments.
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Figure 12. Comparison between theory and simulation for an exponentially
growing population with ρ = 0.5 and ε = 0.0025. The variance at
two positions is averaged over 10,000 runs. The simulation is rep-
resented by the black dots, and the theory by the dashed red line.
Confidence intervals (±1.96 times the standard deviation over runs)
are represented by vertical gray segments.
42
0 1 2 3 4 5
-0
.0
00
05
0.
00
00
0
0.
00
00
5
0.
00
01
0
0.
00
01
5
Covariance, Rec=0.5, 10K runs
Generations
C
ov
ar
ia
nc
e 
be
tw
ee
n 
po
sx
 a
nd
 p
os
y
Initial HD drawn from rpois(lambda=10), 100 seqs
Figure 13. Comparison between theory and simulation for an exponentially
growing population with ρ = 0.5 and ε = 0.0025. The covariance
between two positions is averaged over 10,000 runs. The simulation
is represented by the black dots, and the theory by the dashed red
line. Confidence intervals (±1.96 times the standard deviation over
runs) are represented by vertical gray segments.
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Figure 14. Comparison between theory and simulation for an exponentially
growing population with ρ= 0.5 and ε= 0.0025. The left panel rep-
resents the total mean, and the right panel the total variance, both
averaged over 10,000 runs. The simulation is represented by the
black dots, and the theory by the dashed red line. Confidence inter-
vals (±1.96 times the standard deviation over runs) are represented
by vertical gray segments. In the left panel, the first few generations
are omitted. The theory we have developed neglects early stochastic
events, which are of the order 1N , where N is the sample size. Hence,
we find that only when the sample size is large enough, do theory
and simulation overlap.
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C H A P T E R 4
TWO-SAMPLE TEST FOR COMPARING
INTRA-INDIVIDUAL GENETIC SEQUENCE
DIVERSITY
4.1 Introduction
We have seen how genetic distances are a convenient measure to use in population
genetics. Hamming distances in particular are extremely advantageous to quantify ge-
netic diversity, which, in the case of HIV, correlates well to predictors of disease progres-
sion [28, 29]. So far we have described how to calculate useful statistics within samples
in order to make inferences on the viral evolution. However, there are situations in which
it is interesting to look at characteristics across samples, such as a comparison of mean
HDs between two populations. For example, we have recently attained whole genome
data from early HIV infections [25]. Due to technical constraints, the full genomes were
obtained in two halves, and therefore, an interesting question is whether the mean HD
is significantly different between the two halves. Should this be true, we could argue
that selection is already playing a role in the infection, or, alternatively, the mutation rate
differs between the two genome halves.
The obstacle we encounter when testing for differences in mean HD is the following:
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intersequence distances are not independent. For example, the HD between sequences
i and j is correlated to the HD between sequences i and l because a random change in
sequence j will cause a change in both distances.
In this chapter we propose a two-sample statistic, which was first described in [22].
In that paper, the authors use the usual definition of a T-statistic as the difference in
sample means divided by the variance estimator. However, we found that the variance
estimator they present carries a bias of the order of 1N , where N is the sample size. Given
the typical sample size we see in most applications, this bias often turns out to be quite
sizable. Furthermore, in [22] the authors use a normal approximation of the Student dis-
tribution in order to compute the corresponding P-values.
Unfortunately, large samples are not always feasible in real-life biological scenarios, and
using the methods proposed in [22] when the sample size is low leads to unacceptably
large false positive rates. In this chapter, we first define a new estimator for the sampling
variance of the sample mean of the intersequence HDs. We show that it is indeed unbi-
ased and use the Welch-Satterthwaite approximation to compute the degrees of freedom,
thus avoiding the use of a normal approximation.
The strategy, here, is to take the intersequence HD variance-covariance matrix and project
it onto independent subspaces in order to find a subset of independent variables and
use Cochran’s theorem [8] to define the T-statistic. We block-diagonalize the variance-
covariance matrix using Laplacian graph algebra thus projecting it onto a subspace of
independent variables. Finally, we use a simulation to compare the performance of the
statistic proposed in [22] to our unbiased statistic both with the Welch-Satterthwaite and
with the normal approximation.
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4.2 A proposed two-sample test
In [22], Gilbert et al. present a test for comparing intra-individual genetic sequence
diversity between populations which addresses the issue of correlation between interse-
quence distances. Unfortunately, we discovered that the the estimators for the variances
and covariances of inter-sequence genetic distances used there make it difficult to apply
the test to modestly sized samples, which typically occur in practice. In this chapter, we
show how to correct this deficiency and verify it by explicit simulation of the appropriate
null model.
Following the notation in [22], let µˆ be the sample mean, also called empirical mean,
of the pairwise Hamming distances Di j between sequences i and j from a sample of size
N
µˆ =
[
N(N−1)
2
]−1
∑
i< j
Di j . (4.1)
In the simplest case of two independent samples with mean Hamming distances re-
spectively µ1 and µ2, in [22], Gilbert et al. define the following statistics for evaluating
the null hypothesis H0 : µ1 = µ2
Tpooled =
µˆ1− µˆ2√
Var(µˆ1)+Var(µˆ2)
, (4.2)
which is approximately normally distributed for large sample sizes. For small samples,
the authors suggest the use of Welch-Satterthwaite approximation to calculate the appro-
priate degrees of freedom for a t-test, though they do not carry out the computation in
the paper (hence why we felt necessary to do it here).
This proposed test needs the sampling variance of µˆ, Var(µˆ). The problem with
estimating this variance is, again, that the Di j’s are not independent observations. To
circumvent the problem, Gilbert et al. suggest to use the theory of U-statistics [38] and
estimate Var(µˆ) from the variances and pairwise covariances of the Hamming distances.
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The advantage of this is that the results are blind to the nature of the correlation and only
assume that the sequences are sampled independently in each subject. This independent
sampling means that the population variance-covariance matrix can be written in terms of
only two independent parameters. Again, following previous notation, let σ22 =Var(Di j)
be the variance of the distribution of Hamming distances, and σ21 = Cov(Di j,Dik) be the
covariance between the Hamming distances of pairs sharing one sequence.
Then, it is shown in [22] that the required sampling variance is given by
Var(µˆ) =
[
N(N−1)
2
]−1 [
2(N−2)σ21+σ22
]
. (4.3)
This formula requires the estimation of σ21 and σ
2
2 from the sample. The estimators used
in [22], however, have an O(1/N) bias, which arises from the same non-independence of
the Di j. Note that this bias in σ1 provides an error that is of the same order as the entire
contribution of the σ2 term itself, and turns out to be important for the sample sizes of
interest in many applications. In the rest of the chapter we determine the correspond-
ing unbiased estimators and use a simulation to compare our improvement over the test
proposed in [22].
4.3 Unbiased estimators
Let N be the number of sequences sampled, and Di j the Hamming distance between
sequence i and sequence j. We define
σ˜21 ≡ ∑
i< j<l
[
(Di j− µˆ)(Dil− µˆ)+(Di j− µˆ)(D jl− µˆ)+(Dil− µˆ)(D jl− µˆ)
]
(4.4)
and
σ˜22 ≡∑
i< j
(Di j− µˆ)2 . (4.5)
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The expression for σ˜21 is proportional to a symmetrized version of the estimator σˆ
2
1 used
in [22]; we prefer to use this since it has a lower sampling variance. The improve-
ment demonstrated here is, however, not sensitive to this precise choice. We aim to find
unbiased estimators of σ21 and σ
2
2 in the linear span of these two statistics. In terms
of E(Di j) ≡ µ, we can write E(D2i j) = σ22 + µ2, E(Di jDik) = E(Di jDki) = σ21 + µ2 and
E(Di jDkl) = E(Di j)E(Dkl) = µ2, when i, j and k, l refer to non-overlapping indices. A
little algebra shows
E(σ˜21) = (N−2)
[
−σ22+
N2−5N+8
2
σ21
]
, (4.6)
and
E(σ˜22) = (N−2)
[
N+1
2
σ22−2σ21
]
. (4.7)
Using these, one can find
E(S2) =
[
N(N−1)
2
]−1 [
2(N−2)σ21+σ22
]
= Var(µˆ) , (4.8)
where,
S2 ≡ 4 (2σ˜
2
1+ σ˜
2
2)
N(N−1)(N−2)(N−3) . (4.9)
Notice that, contrary to the formulae in [22], these estimates require the sample size
N to be larger than 3. This is, in fact, expected, since for N = 3, every pair of inter-
sequence distances refer to a common sequence, and it should not be possible to extract
independent estimates of σ˜1 and σ˜2, nor is there enough information to calculate the
sampling variance of the mean.
We note that the intersequence distances are not normally distributed, as in fact they
are always positive. Nevertheless, we show by simulations below that, even for rather
small samples, the use of (Eq. 4.9) to estimate the denominator in (Eq. 4.2) leads to an
acceptable test statistic.
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4.4 Welch-Satterthwaite approximation
To extend these results, we calculate the degrees of freedom needed to use the t-
test instead of the normal approximation for small samples as proposed in [22]. Recall
that a random variate T is t-distributed if there exist independent variates Z and C such
that T = Z√
C/ν
where Z is normally distributed, and C is χ2-distributed with degrees of
freedom ν.
Consider a set of N sequences with pairwise Hamming distances {Di j} drawn from
a population described by µ,σ1,σ2 as defined in the Introduction. Let Σ be the variance-
covariance matrix of D ≡ {Di j}. Let U be the set of all pairs u = (i j) with i < j and
i, j = 1, ...,N, so that we can write {Di j}= (Du|u∈U). Then, assuming that all distances
are equally distributed, for every u,v ∈U
Σu,v =

σ1 if u 6= v but u∩ v 6= /0
σ2 if u = v
0 if u∩ v = /0
(4.10)
One can see that Σ=−σ21LN+[σ22+2(N−2)σ21] I, where I is the M-dimensional identity
matrix, M =
N(N−1)
2 , and
(LN)u,v =

−1 if u 6= v but u∩ v 6= /0
2(N−2) if u = v
0 if u∩ v = /0
(4.11)
LN is the graph Laplacian of the edge graph of the complete graph on N vertices. Clearly
LN and Σ have the same eigenvectors. LN can be diagonalized using the representations
of the permutation group of N elements. In particular, we find the following eigenvectors:
• One eigenvector e0 = (1, ...,1), with eigenvalue λ0 = 0;
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• N− 1 eigenvectors defined as eki j = N(δik + δ jk)− 2 (where δ is the Kroenecker
delta) for k = 1, ...,N− 1, with eigenvalue λ1 = N (notice that even though there
are N such vectors, the relationship ∑k ek = 0 gives a linear dependence in the set);
• For k, l = 1, ...,N, define the eigenvector
ekli j =

N−3 if u 6= v but u∩ v 6= /0
−(N−2)(N−3) if u = v
−2 if u∩ v = /0
(4.12)
Since for every k, ∑i 6=k eik = 0, that leaves
N(N−3)
2 independent eigenvectors with
eigenvalue λ2 = 2(N−1).
In conclusion, we have found
N(N−1)
2 independent eigenvectors, corresponding to three
eigenvalues λ0,λ1, and λ2. Let E be the matrix whose columns are the
N(N−1)
2 inde-
pendent eigenvectors. We define a matrix F by defining its rows. Let f0 =
2e0
N(N−1) . For
k = 1, ...,N, let f k = e
k−eN
N2(N−2) . And finally, for u = (kl) define
f kl = e
i j−eiN−e jN−eN−2,N−1+eN−2,N+eN−1,N
(N−1)2(N−2)2 .
One can verify that FE = I and therefore Σ−1 = E∆−1F , where ∆ is a diagonal matrix
with three distinct elements. Given all of the above, we obtain
(D−µ)Σ−1(D−µ)T = Z2+CN−1+CN(N−3)/2 , (4.13)
where,
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Z =
√
N(N−1)
2
(D¯−µ)√
σ22+2(N−2)σ21
, (4.14)
CN−1 =
(N−1)2
N−2
∑Ni=1(D¯i− D¯)2
σ22+(N−4)σ21
, (4.15)
CN(N−3)/2 =
∑i< j
[
Di j− D¯− N−1N−2
(
D¯i+ D¯ j−2D¯
)]2
σ22−2σ21
, (4.16)
and
D¯ =
2
N(N−1)∑i< j
Di j , (4.17)
D¯i =
1
N−1∑j 6=i
Di j . (4.18)
If the distribution of D can be approximated as a multivariate normal form, by Cochran’s
theorem [8], Z, CN−1, and CN(N−3)/2 are independent, Z is normally distributed, and the
Cν’s are chi-square distributed with degrees of freedom ν.
Furthermore, we can write
S2 =
1
a+b
(
a
CN−1
N−1 +b
CN(N−3)/2
N(N−3)/2
)
, (4.19)
where,
a =
2(N−1)
N−2
(
σ22+(N−4)σ21
)
, (4.20)
b = − N
N−2
(
σ22−2σ21
)
. (4.21)
Note that since b is negative, S2 is not positive semi-definite. The issue is shared by
the expression used in [22], and distinguishes this problem from that considered by Sat-
terthwaite and Welch [63, 77]. However, b is zero when the intersequence Hamming
distances Di j can be written as the sum D0i +D
0
j of distances of each sequence from a
common ancestor; i.e., when the underlying sequence set is phylogenetically indepen-
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dent, or, in other words, when the phylogeny is ‘star-like’. In the more general case, S2
has unit mean and the same variance as a chi-square variate, scaled to unit mean, with
degrees of freedom given by
ν =
(a+b)2
a2
ν2 +
b2
ν3
(4.22)
=
(σ22+2(N−2)σ21)2
4(N−1)
(N−2)2
(
σ22+(N−4)σ21
)2
+2 N
(N−2)2(N−3)
(
σ22−2σ21
)2 (4.23)
We can obtain a simple estimate of ν (not unbiased) in terms of σ˜21 and σ˜
2
2 as defined in
Equation ( 4.4) and Equation ( 4.5) by noting that
E
[
2
(N−2)(N−3)
(
σ˜22+2σ˜
2
1
)]
= σ22+2(N−2)σ21, (4.24)
E
[
2
(N−1)(N−2)
(
σ˜22+ σ˜
2
1
)]
= σ22+(N−4)σ21, (4.25)
E
[
2
N(N−2)(N−3)
(
(N−4)σ˜22−2σ˜21
)]
= σ22−2σ21, (4.26)
Because of the negative coefficient (Eq. 4.21), this is not the Welch-Satterthwaite ap-
proximation in sensu stricto.
4.5 Simulation results
To test our formulae, we simulate a population of independent random sequences.
We then randomly draw two samples and test the difference in means using both the
statistic defined in [22] and our improved one. To compare directly with the explicit
formulae provided in [22], we display and discuss both the results from using a normal
approximation and from performing the actual t-test as illustrated above. Given that the
two samples are drawn from the same population, we expect a p value of 0.05 or lower
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5% of the times, for asymptotically large samples.
In Table 1, we show the efficacy of using the estimate of the degrees of freedom to
improve the z-test to a t-test for the small sample case with a sample with typical dis-
tances set to a moderate value of 20. In the case of star topology, the t-test is essentially
exact for all sample sizes, and even the normal approximation using the unbiased esti-
mators performs reasonably down to a sample size of about 30. In contrast, using the
variance estimates presented in [22], rather large deviations are seen even at a sample
size of 50. For the non-star case, the t-test becomes noticeably over-conservative below
a sample size of about 20, but the normal approximation errs in the opposite direction,
and still performs noticeably better than when using the estimators presented in [22].
Star topology Non-star topology
N GRS z-test t-test GRS z-test t-test
4 0.280 0.101 0.050 0.099 0.070 0.020
5 0.260 0.084 0.049 0.126 0.097 0.016
8 0.151 0.069 0.048 0.123 0.085 0.023
10 0.126 0.067 0.054 0.106 0.070 0.032
20 0.081 0.058 0.051 0.067 0.055 0.046
30 0.070 0.055 0.053 0.054 0.054 0.047
50 0.061 0.053 0.049 0.045 0.051 0.045
100 0.053 0.048 0.053 0.039 0.049 0.051
Table 1. Fraction of 10,000 samples that result in p≤ 0.05 for a variety of tests.
Column N gives the sample size, whereas the columns GRS, z-test, and
t-test refer to the tests as described in [22], our z-test implemented
with the unbiased variance estimator we calculated, and our t-test im-
plemented using the Satterthwaite and Welch approximation respec-
tively. In the star topology, the branch lengths of the phylogenetic
tree were distributed according to a Poisson of mean 10. The non-star
topology consisted of two stars with Poisson distribution with means
10 and 5 respectively, connected by a branch of length 12. Neglecting
the non-normality of the branch-length distributions in the tree, the
Satterthwaite-Welch approximation is exact for the star topology.
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4.6 Discussion
In this chapter, we have improved the statistics proposed in [22] and used a simulation
to validate our findings. We have also computed the degrees of freedom for performing
an approximate t-test using the Welch-Sattherthwaite formula. The t-test is close to ex-
act when the underlying sequences have no phylogenetic structure, and is conservative
otherwise. The original test, on the other hand, provides an inadequate control of type I
errors for moderate sample sizes.
Applications of our statistic are multiple: we have recently used it to compare dif-
ferent genome halves obtained for a set of patients, and we were able to see that, in the
absence of selection, the mutation rate is the same across the two halves. Another sce-
nario where our statistic is particularly useful is in vaccine design, when it’s important
to compare the HD between different populations (vaccinated and non-vaccinated). In
both scenarios we have seen sample sizes as low as N = 4, which would have led to
unacceptably biased results were one to use the statistic proposed in [22].
The R code [57] implementing the new proposed statistic is available for download
at ”ftp://ftp-t10.lanl.gov/pub/TwoSampleTTest/”.
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C H A P T E R 5
CONCLUSIONS
5.1 Overview
In the first chapter of this thesis we discussed a model of neutral viral evolution,
which is applicable to early HIV infection. The model characterizes the genetic diversity
of the viral population in individuals whose viral load is either still increasing or just
off the peak. The time estimates yielded by the model compare well with the clinical
data from most samples we looked at. When the comparison is off, the model is still
informative as it prompts further investigation on the nature of the divergence.
By applying our model, we have been able to confirm a frequency of roughly 80%
homogeneous infections among heterosexual transmissions. This has been observed in
both the HIV B-clade and C-clade [34, 1], as well as in monkey studies inoculated in-
trarectally with SIV [35]. Another successful application of our model has been in timing
the start of immune responses. While there was widespread belief that the host immune
selection wouldn’t start until 2-3 months into the infection, and that the negative slope
in viral load at six weeks was due to the rapid depletion of target cells [53], we were
able to observe that viral escapes to T-cell response arise much earlier, between 4 and 6
weeks, and that T-cells do indeed have a role in controlling the viral load this early in the
infection [25, 19]. These findings are important for vaccine design, as they tell us that a
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vaccine able to elicit strong and broad T-cell responses early in the infection is likely to
be successful in controlling viral loads.
The model of early HIV evolution has been implemented in a webtool available on
the LANL server [55]. Since the user can specify different mutation rates on input, it
can be used with species different from HIV that have a similar genetic behavior (e.g.
the Hepatitis C virus). It can also be used on longitudinal data in order to determine the
within patient mutation rate and see how it varies across individuals. With the advent of
deep sequencing methods [43], which often yields tens of thousands of sequences, our
tool is currently the only computationally efficient way to deliver this kind of analyses.
Coalescent and tree-based methods, because they simulate genealogies and do not take
advantage of the homogeneity of the data, cannot handle these massive datasets.
In the second chapter we introduce recombination in the model and compare our the-
oretical results with those obtained through simulation. We notice that while recombina-
tion does not affect the overall behavior of the mean genetic diversity it does, however,
change its sample variance.
Finally, the third chapter was motivated by the need of comparing the mean Hamming
distance across different populations. We found that the statistic proposed in previous
work [22] had an unacceptably high bias and used a normal approximation that holds
only for large sample sizes. Therefore, in Chapter 3 we presented a statistic that corrects
the bias and used a Welch-Satterwaithe approximation instead of the normal approxi-
mation. Simulations showed that our statistic performed well even with sample sizes as
small as N = 5, which is quite common. Therefore our statistic is a new, important tool
in many biological scenarios such as vaccine design, where it is important to test for HD
differences between the vaccinated and non-vaccinated population.
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5.2 Work in progress
5.2.1 Continuous models
The infection models presented in Chapter 1 are simplifications of the true biology
of HIV replication. We are currently investigating how such simplifications affect our
analysis of the viral evolution. Let I(a,g, t) be the number of infected cells of age a and
generation g (i.e. the HIV genome has undergone g replication cycles since the founder
strain) at time t. Here a and t are continuous variables, whereas g is discrete. Assume
that the death and birth rate of a infected cells, i.e. the rate at which infected cells die or
produce newly infected cells, only depend on how long the cell has been infected. We
denote such rates β(a) and α(a) respectively. The resulting birth and death process is
fully described by a system of two equations called the Von Foerster equation and the
renewal condition [59], respectively:
∂
∂t I(a,g, t)+
∂
∂aI(a,g, t) =−I(a,g, t)β(a)
I(a,g+1, t) =
∫ t
0 I(a,g, t)α(a)da
(5.1)
with initial condition
I(a,g,0) =

I0 if a = g = 0
0 otherwise.
(5.2)
The above is still a deterministic approach. The fully random process is described
by a master equation in the probability distribution P. Namely, denote U =R+×Z+ the
space of all pairs u = (a,g). Let α(u) and β(u) be the birth and death rates, respectively.
A state of the system is a function I : U → Z+ that to every u ∈U associates a positive
integer I(u) = I(a,g), which represents the number of infected cells of age a and gener-
ation g.
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LetW be the space of all suitable functions I : U → Z+. At any given time t ∈ R+,
and for any given state I ∈W , let P(I; t) be the probability of the system being com-
pletely described by the state I at time t. Even though technically we have P :W ×R+→
[0,1], for simplicity we omit the dependency in time and consider P as an element in
S(W ),where S(W ) =
{
W → [0,1]}, the space of all operators from W into [0,1]. We
obtain the following master equation:
∂P
∂t (I; t)−
∫
U
∂I
∂a(u)
∂P
∂I(u)(I; t) du =
=
∫
U
β(u)
[
P(I; t)+ ∂P∂I(u) (I; t) I(u)
]
du
−
∫
∂U
α(u)
[
P(I; t)− ∂P∂I(u) (I; t) I(u)
]
du
−
∫
U
∂P
∂I(0,g+1) (I; t) I(u) α(u) du
(5.3)
where ∂U = {u = (a,g) ∈U | a = 0, g > 0}.
When α and β are constants, by using the fact that
∫
U I du = N, the total number
of cells, one obtains the classical birth and death process. Namely, let P(N; t) be the
probability that at time t there is a total of N infected cells in the system, for any given
state I such that
∫
U I du = N. The system becomes
∂P
∂t = α(N−1)P(N−1; t)+β(N+1)P(N+1; t)−N(α+β)P(N; t). (5.4)
This is fully discussed in [59], where a full solution is given in terms of the generating
function F(z; t) = ∑N P(N; t) zN by
F(z; t) =
[
β(z−1)e(α−β)t−α z+β
α(z−1)e(α−β)t−α z+β
]N0
(5.5)
where N0 is the initial number of infected cells.
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5.2.2 Simulations
We devise a simulation to follow the growth of the infection cell population according
to a completely random, continuous model. We use linear birth and death rates, and then
sample the population each day into the infection to study the increase of mean HD over
time.
 
•    
! Average of mean 
inter-sequence HD 
over 1,000 runs. 
! Mean inter-sequence  
HD (1 run only).     
Sample size: 30 sequences.   
Sequence length: 2,600 bps.   
 PURPOSE OF OUTPUT: 
a) When did the infection start?  
b) Is the mean HD compatible with a single-strain 
infection? 
 
MEAN HD FROM SIMULATION OUTPUT 
  
M
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n 
H
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m
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D
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Figure 15. Simulation output from 1,000 runs with linear death and birth
rates. In each run, we generate the infected cell population start-
ing from one sequence of length NB = 2,600 base pairs. Each day
into the infection, we sample N = 30 sequences and calculate the
mean HD. The blue dots show the mean HD of one particular run,
with 95% CIs indicated by the vertical dashed lines. The red dots
show the mean HD over the 1,000 runs, thus retrieving the linear
behavior we expected.
As shown in Figure 15, single runs are subject of random fluctuations of the order of
1
N , where N is the sample size. However, when we average over 1,000 runs, we see that
the mean HD grows linearly with time, just like we had seen with the synchronous and
asynchronous model.
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5.3 Future directions
We are about to obtain longitudinal samples from large cohorts, which will allow
to quantify the variation of mutation rate across patients. For the first time we will have
multiple time points within one week from one another, and mostly obtained in the ramp-
up phase of the viral load (prior to the peak), which is the ideal framework for our model.
Furthermore, thanks to the wide availability of deep sequencing data, we will continue
to test the pattern we had already seen with cohorts of 10-60 sequences, i.e. the fact that
80% of heterosexually transmitted infections are homogeneous.
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A P P E N D I X A
Mathematical Derivations from Chapter 1
Claim A.1. Given a genome of NB positions, which has undergone g replication cycles
from the founder strain, with a mutation rate per site per generation of ε, then
P(HD0 > NB|g)≤ O
(
g2ε2
NB
)
 1 (A.1)
where HD0 is the number of mutations from the founder strain.
Proof. Chebyshev’s inequality [17] states that, given a random variable X with mean µ
and variance σ2, for any positive integer k, one has
P(X−µ≥ kσ)≤ 1k2 (A.2)
Let X be the number of mutations from the consensus (HD0); then µ = gεNB, and σ2 =
gεNB(1− ε). Take k such that kσ+µ = 1+NB. In other words
k2 =
(
1+NB−µ
σ
)2
=
(1+NB−gεNB)2
gεNB(1−ε) (A.3)
Then
P(HD0 ≥ NB+1|g)≤ gε(1−ε)
NB
(
1+ 1NB−gε
)2 ≈ gε(1−ε)NB +O
(
g2ε2
NB
)
 1 (A.4)
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Claim A.2. Given the asynchronous model described in section 1.3.2, at any time t and
n =
⌊ t
τa
⌋
, the number of infected cells which have undergone g replication cycles from
the founder strain are given by
Ig(n) = I0 αn
( γ
α2
)n−g g
n−g
 for g = ⌈n2⌉ , ...,n, and 0 otherwise. (A.5)
Proof. Using the notation introduced in 1.3.2, notice that at time n+ 1, of all cells
Ig+1(n+ 1), αIg(n) were born at time t, whereas γIg(n− 1) were born at time n− 1.
Therefore
Ig+1(n+1) = αIg(n)+ γIg(n−1) (A.6)
Using the binomial expansion x+1
y− x
=
 x
y− x
+
 x
y− x−1
 (A.7)
one can see that the expression in (A.5) satisfies equation (A.6) for
⌈n
2
⌉
≤ g≤ n.
Lemma A.3. Like before, let Ig(n) be the number of infected cells which have undergone
g replication cycles from the founder strain at time t, and let n =
⌊ t
τa
⌋
. Le I0 be the
number of infected cells at time t = 0. Then
n
∑
g=
⌈n
2
⌉ Ig(n) = I02ϕ
(α
2
)n [
(1+ϕ)n+1− (1−ϕ)n+1]= I0αnFn (A.8)
where
Fn =
(1+ϕ)n+1−(1−ϕ)n+1
2n+1ϕ and ϕ=
√
1+4
γ
α2 (A.9)
Proof. Let N(n) =∑n
g=
⌈n
2
⌉ Ig(n). Summing both sides of Equation (A.6) over g, one can
see that N(n) satisfies
N(n+1) = αN(n)+ γN(n−1) (A.10)
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Let λ1 = α2 (1+ϕ), and λ2 =
α
2 (1−ϕ), the roots of the equation x2 = αx+ γ. It follows
that for every integer a and b Na,b(n) = aλn1+bλ
n
2 also satisfies equation (A.6).
In order to satisfy the initial conditions N(0) = I0 and N(1) = αI0, we choose a= I0
1+ϕ
2ϕ
and b =−I0 1−ϕ2ϕ , which yield
N(n) =
I0
2ϕ
(α
2
)n [
(1+ϕ)n+1− (1−ϕ)n+1] (A.11)
Corollary A.4. Define
Fn(x) =
n
∑
g=
⌈n
2
⌉xn−g
 g
n−g
 (A.12)
Then
Fn(x) =
(1+ϕ)n+1−(1−ϕ)n+1
2n+1ϕ (A.13)
where ϕ= ϕ(x) is defined as in Equation (A.9).
Claim A.5. Let x =
γ
α2 . Given the asynchronous model described in section 1.3.2, the
corresponding HDI probability distribution is given by
P(HDI = d|n) = 1Fn(x)
n
∑
g=
⌈n
2
⌉
 g
n−g

 2gNB
d
xn−g εd(1− ε)2gNB−d (A.14)
Proof. Substitute equation (A.11) into equation (2.10).
Corollary A.6. Given the moment generating function of P(HDI|n), defined as M(n)HD(ξ)=
∑HDI P(HDI|ξ), we have
M(n)HD(ξ) =
1
Fn(x)
n
∑
g=
⌈n
2
⌉
 g
n−g
xn−g [εeξ+(1− ε)]2gNB . (A.15)
it follows that
M(n)HD(ξ) =
[
εeξ+(1− ε)
]2nNB Fn(x[εeξ+(1−ε)]−2NB)
Fn(x)
(A.16)
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Proof. Write [
εeξ+(1− ε)
]2gNB
=
[
εeξ+(1− ε)
]2nNB−2NB(n−g)
(A.17)
and then use Corollary A.4.
Claim A.7. In the limit NB → ∞, for n 1 there exists a λn such that P(HDI|n) ≈
Pois(d,λn)+O(ε2N2B) and hence, like in the synchronous model, up to second degree
terms in ε, the intersequence HD’s follow a Poisson distribution.
Proof. Let θ= εNB. For fixed θ, we have
lim
NB→∞
[
εeξ+(1− ε)
]NB
= Exp
(
θ
(
eξ−1
))
(A.18)
from which it follows that
lim
NB→∞
M(n)HD(ξ) = Exp
(
2nθ
(
eξ−1
)) Fn(x Exp(−2θ(eξ−1)))
Fn(x)
(A.19)
Therefore, in the NB 1 limit, the cumulant generating function is given by
K(n)HD(ξ) = 2nθ
(
eξ−1
)
+ log
[
Fn(x Exp(−2θ(eξ−1)))
Fn(x)
]
(A.20)
When expanding the second term in θ one gets
log
[
Fn(x Exp(−2θ(eξ−1)))
Fn(x)
]
=−4x F
′
n(x)
Fn(x)
θ
(
eξ−1
)
+O(θ2) (A.21)
where F ′n(x) is the first derivative with respect to x. Remember that x =
γ
α2 , and from
Equation (A.9) it follows that x =−(1−ϕ)(1+ϕ)4 . Using this, and given that 0 <
1−ϕ
1+ϕ<
1, one finds that for n 1
−4x F
′
n(x)
Fn(x)
≈ (1−ϕ)(nϕ−1)ϕ2 (A.22)
Substituting in (A.20)
K(n)HD(ξ)' θ
(
eξ−1
)(
n
1+ϕ
ϕ +
1−ϕ
ϕ2
)
+O(θ2). (A.23)
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The above is the cumulant generating function of a Poisson distribution with parameter
θ
(
n
1+ϕ
ϕ +
1−ϕ
ϕ2
)
. Hence, we conclude that for n 1 and up to terms in O(ε2N2B),
λn = εNB
(
n
1+ϕ
ϕ +
1−ϕ
ϕ2
)
(A.24)
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A P P E N D I X B
χ2 Goodness-of-Fit test for Non-Independent Data
Given N observations, we want to test whether they belong to a given distribution P.
We use the following [5]:
Claim B.1. Let X j for j = 1, ...,N be a family of independent random variables such
that X j ∼ N(0,1) for every j, where N(0,1) is the standard normal distribution. Then
χ2 = ∑ j X2j is asymptotically chi-squared distributed with N−1 degrees of freedom.
Denote O j the N observations, and E j the expected values when the observed draw-
ings are P-distributed. Then Z j =
O j−E j√
E j
are N independent random variables, each
following a standard normal distribution. Therefore, by virtue of claim B.1, given T =
∑ j Z2j , T is asymptotically chi squared.
In the context of our model, given a sample of genetic sequences, let the observed
values Yj, for j = 0, ...,M, be the frequency counts of the intersequence Hamming dis-
tances. M is the maximum observed intersequence HD. In order to test this hypothesis,
we define the random variable T as
T = (Y −E(Y ))t Σ† (Y −E(Y )) . (B.1)
where Σ† is the pseudoinverse of the covariance matrix:
Σi, j = σi j = E(YiY j)−E(Yi)E(Yj) (B.2)
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Claim B.1 tells us that T is chi-squared distributed. If the Yi’s were all independent,
then Σ† would be the actual inverse of the covariance matrix, and T would have M de-
grees of freedom. However, as we have already pointed out, the intersequence Hamming
distances are not all independent. In fact, in this case Σ will have a non-zero kernel.
Here, the null hypothesis is that the given sample of sequences are Poisson-distributed
and derived from a star-phylogeny. Even if the original sample does not follow a star-
phylogeny, given how we perform the goodness of test, we are basically projecting to the
best star possible and use it as our error model.
This is how we compute Σ and its pseudoinverse. Let Xi be the frequency count of the
Hamming distance with respect to the consensus. Under the star-phylogeny assumption,
we have
Yk =
1
2
k
∑
j=0
X j(Xk− j−δ j,k− j) (B.3)
where δk,l denotes the Kronecker delta. Here, we assume X j = 0 for j = m+ 1, ..,M,
where m is the integer part of M2 . There are m non-zero Xi’s, related by the equation
λ = ∑ j j X j, and hence the correct number of degrees of freedom for the T statistic is
m−1. Therefore
E(Yk) =
1
2
k
∑
j=0
[
E(X jXk− j)−δ j,k− jE(X j)
]
. (B.4)
We have seen that under the star-phylogeny assumption, we expect the Y j’s to follow a
Poisson distribution Pois(2λ), where λ is the mean of the HD0 values (Hamming distance
from the consensus). Hence
E(Yk) = c2 2k−1 e−2λ
λk
k! (B.5)
where c = N0, the sample size.
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To compute E(YkYl), write:
YkYl =
1
4
[(
∑kj=0, j 6= k2
X jXk− j
)(
∑li=0,i6= l2
XiXl−i
)
+
(
X k
2
−1
)
X k
2
∑li=0,i 6= l2
XiXl−i+
+
(
X l
2
−1
)
X l
2
∑kj=0, j 6= j2
X jXk− j +X k
2
X l
2
(
X k
2
−1
)(
X l
2
−1
)]
(B.6)
where the additional terms in the summation are present only when either k or l or both
are even. Using the independence of the X j’s, we get:
E(YkYl)=

c4 2k+l−2 e−4λ λ
k+l
k! l! when both k and l are odd;
c3 2l−2 e−3λ λ
k
2+l
( k2)! l!
c e−λ ( k2)! λ k2k! −1
 when k is even and l is odd;
2k−2 e−λ(λ+λ2)(2le−λ−1) when l is even and k is odd;
(λ+λ2)
4 (2
k+le−2λ− (2l +2k)e−λ+1) when both l and k are even.
We substitute the above in equation (B.2) and then use Singular Value Decomposition
(implemented in R through the function Ls.svd) to find the pseudoinverse of Σ.
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